Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
- PMID: 30474171
- DOI: 10.1002/ajh.25362
Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation
Publication types
MeSH terms
Substances
Grants and funding
- PROGRES Q28/LF1/Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations/International
- PROGRES Q26/LF1/Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations/International
- UNCE/MED/016/Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations/International
- AZV 17-28980A/Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations/International
- Charles University Center of Excellence/International
LinkOut - more resources
Full Text Sources
